Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: How should we counsel cancer patients about breastfeeding?

Barbara Pistilli, Giulia Bellettini, Elisa Giovannetti, Giovanni Codacci-Pisanelli, Hatem A. Azim, Giovanni Benedetti, Maria Anna Sarno, Fedro A. Peccatori

Research output: Contribution to journalArticle

Abstract

An increasing number of women are diagnosed with cancer during pregnancy and lactation. Women are usually advised to interrupt breastfeeding during systemic anticancer treatment for fear of serious adverse effects to the nursed infant. However, the issue is poorly addressed in the literature and very few studies have evaluated the safety of breastfeeding during or after cytotoxic drugs or target agents administration. In this review we will analyze the available evidence that addresses the issue of anticancer drugs, targeted agents, antiemetics and growth-factors excretion in human milk. This could serve as a unique resource that may aid physicians in the management of breastfeeding cancer patients interested in maintaining lactation during treatment.

Original languageEnglish
Pages (from-to)207-211
Number of pages5
JournalCancer Treatment Reviews
Volume39
Issue number3
DOIs
Publication statusPublished - May 2013

Keywords

  • Antiemetics
  • Breastfeeding
  • Cancer
  • Chemotherapy
  • Growth factors
  • Milk
  • Pharmacokinetics
  • Targeted agents

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: How should we counsel cancer patients about breastfeeding?'. Together they form a unique fingerprint.

  • Cite this